Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-12

FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) submitted by Chattem, Inc., likely updating or expanding its lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLEGRA HIVES 24HR (fexofenadine hydrochloride)

Snippet

SUPPL AP for ALLEGRA HIVES 24HR (FEXOFENADINE HYDROCHLORIDE)